TP53 and cancer: More than a thousand p53 mutations have been documented in cancer, classified as either structural, that is, inducing conformational changes (e.g., R175H, R249S, and R282W); contact mutations, which disrupt p53’s ability to interact with its consensus sequences (R248W and R273W); and null mutations, resulting in an absence of p53 protein (10,11).